Search Results - "Fields, Jerel Adam"

This result is not displayed to guests.
Login for full access.

Elevated Biomarkers of Inflammation and Vascular Dysfunction Are Associated with Distal Sensory Polyneuropathy in People with HIV.

Authors: Andalibi, Mohammadsobhan Sheikh Fields, Jerel Adam Iudicello, Jennifer E. et al.

Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 8, p4245. 11p.

Caloric Restriction Mimetic 2-Deoxyglucose Reduces Inflammatory Signaling in Human Astrocytes: Implications for Therapeutic Strategies Targeting Neurodegenerative Diseases.

Authors: Vallee, Kaylie-Anna Juliette Fields, Jerel Adam

Source: Brain Sciences (2076-3425). Mar2022, Vol. 12 Issue 3, p308. 12p.

The 30^th Scientific Conference of the Society on NeuroImmune Pharmacology in Annapolis, Maryland, May 3^rd – 6^th, 2026.

Authors: Chang, Linda Sil, Susmita Fields, Jerel Adam et al.

Source: NeuroImmune Pharmacology & Therapeutics. Mar2026, Vol. 5 Issue 1, p1-77. 77p.

Alterations in brain TREM2 and Amyloid‐β levels are associated with neurocognitive impairment in HIV‐infected persons on antiretroviral therapy.

Authors: Fields, Jerel Adam Swinton, Mary Qvale, Emma Martine et al.

Source: Journal of Neurochemistry. Dec2018, Vol. 147 Issue 6, p784-802. 19p.

Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice.

Authors: Fields, Jerel Adam Swinton, Mary K. Carson, Aliyah et al.

Source: Scientific Reports. 11/20/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders.

Authors: Fields, Jerel Adam Serger, Elisabeth Campos, Sofia et al.

Source: Neurobiology of Disease. Feb2016, Vol. 86, p154-169. 16p.

Caloric restriction mimetic 2-deoxyglucose alters metabolic and transcriptomic phenotype in association with changes in chromatin accessibility in human astrocytes.

Authors: Spencer, Matthew Kulbe, Jacqueline R. Venkatesh, Vikram et al.

Source: Scientific Reports. 6/3/2025, Vol. 15 Issue 1, p1-14. 14p.

Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study.

Authors: Boustani, Ali Ford, Mary K. Kulbe, Jacqueline R. et al.

Source: Brain Sciences (2076-3425). Jan2025, Vol. 15 Issue 1, p49. 14p.

Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis.

Authors: Avalos, Bryant Kulbe, Jacqueline R. Ford, Mary K. et al.

Source: Viruses (1999-4915). Oct2024, Vol. 16 Issue 10, p1509. 27p.

Sera from people with HIV and depression induce commensurate metabolic alterations in astrocytes: toward precision diagnoses and therapies.

Authors: Laird, Anna Elizabeth Le, Alexandra Anh Kulbe, Jacqueline R. et al.

Source: NeuroImmune Pharmacology & Therapeutics. Jun2024, Vol. 3 Issue 2, p113-128. 16p.

Mitochondrial DNA and Electron Transport Chain Protein Levels Are Altered in Peripheral Nerve Tissues from Donors with HIV Sensory Neuropathy: A Pilot Study.

Authors: Boustani, Ali Kulbe, Jacqueline R. Andalibi, Mohammadsobhan Sheikh et al.

Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4732. 13p.

Nicotine, THC, and Dolutegravir Modulate E-Cigarette-Induced Changes in Addiction- and Inflammation-Associated Genes in Rat Brains and Astrocytes.

Authors: Kulbe, Jacqueline Renee Nguyen, Lauren Le, Alexandra Anh et al.

Source: Brain Sciences (2076-3425). Nov2023, Vol. 13 Issue 11, p1556. 14p.

Lipocalin-2 mediates HIV-1 induced neuronal injury and behavioral deficits by overriding CCR5-dependent protection.

Authors: Ojeda-Juárez, Daniel Shah, Rohan Fields, Jerel Adam et al.

Source: Brain, Behavior & Immunity. Oct2020, Vol. 89, p184-199. 16p.

Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders.

Authors: Garces, Armando Martinez, Bryan De La Garza, Roberto et al.

Source: Scientific Reports. 2/25/2023, Vol. 13 Issue 1, p1-17. 17p.

Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder.

Authors: Canchi, Saranya Swinton, Mary K. Rissman, Robert A. et al.

Source: Journal of Neuroinflammation. 4/11/2020, Vol. 17 Issue 1, p1-16. 16p.

Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.

Authors: Ellis, Ronald J. Marquine, María J. Kaul, Marcus et al.

Source: Nature Reviews Neurology. Nov2023, Vol. 19 Issue 11, p668-687. 20p.

GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice.

Authors: Kulbe, Jacqueline Renee Le, Alexandra Anh Mante, Michael et al.

Source: Journal of NeuroVirology. Oct2023, Vol. 29 Issue 5, p564-576. 13p.

Alterations in Brain Cannabinoid Receptor Levels Are Associated with HIV-Associated Neurocognitive Disorders in the ART Era: Implications for Therapeutic Strategies Targeting the Endocannabinoid System.

Authors: Swinton, Mary K. Sundermann, Erin E. Pedersen, Lauren et al.

Source: Viruses (1999-4915). Sep2021, Vol. 13 Issue 9, p1742. 1p.

Correction: GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice.

Authors: Kulbe, Jacqueline Renee Le, Alexandra Anh Mante, Michael et al.

Source: Journal of NeuroVirology. Feb2024, Vol. 30 Issue 1, p101-102. 2p.